Cobo AC, Fabián SMMG, García SFMC, Ramírez VA

Language: Spanish
References: 26
Page: 352-360
PDF size: 305.68 Kb.

ABSTRACT

Chronic Obstructive Pulmonary Disease is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. Our objective was to determine the association of electrocardiographic findings with Chronic Obstructive Pulmonary Disease GOLD IV (of Global Iniciative for Chronic Obstructive Lung Disease) (n=46) in comparison with GOLD 0 (n=20), GOLD I (n=22) and asthma patients (n=30). We analyzed 118 patients. GOLD IV patients shown anomalies in ECG with right heart hypertrophy, which were not observed in GOLD 0 or in patients with asthma. We conclude that in those places without a spirometry in Chronic Obstructive Pulmonary Disease patients, the electrocardiographic changes could be useful to staging of the disease.

REFERENCES

1. Jindal SK, Aggarwal AN, Chaudhry K, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23-9.

2. Warwick H, Doig A. Smoke the killer in the kitchen. Indoor air pollution in developing countries. ITDG Publishing, 103-105 Southampton Row London WC1B HLD, UK 2004. Disponible en: http://www.itdgpublihing.org.uk.

3. Smith KR, Mehta S, Maeusezahl-Feuz M. Indoor air-pollution from household solid fuel use. In: Ezzati M, Lopez, AD, Rodgers M, Murray CJ, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization, 2004.

4. Viegi G, Maio S, Pistelli F, Baldacci S, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. Respirology 2006;11:523-32.

5. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27: 397-412.

6. Murray CJ, Lopez AD. Evidence-based health policy – lessons from the Global Burden of Disease Study. Science 1996; 274: 740-3.

7. Secretaría de Salud. Principales causas de mortalidad general, nivel nacional, 2005. Disponible en: http://www.salud.gob.mx/ apps/htdocs/estadisticas/mortalidad/

8. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81.

9. Segundo consenso mexicano para el diagnóstico y tratamiento de la EPOC. Coordinadores: Raúl H Sansores, Alejandra Ramírez-Venegas. Edición especial del INER y de la Sociedad Mexicana de Neumología y Cirugía de Tórax, Revista del Instituto Nacional de Enfermedades Respiratorias, abril de 2003.

10. Regalado J, Perez-Padilla R, Sansores R, et al. The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care Med 2006;174: 901-5.

11. Aoshiba K. Role of alveolar cell apoptosis in COPD. Nippon Rinsho 2007; 65: 629-32.

12. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27:627-43.

13. Rasche K, Orth M, Kutscha A, Duchna HW. Pulmonary diseases and heart function. Internist (Berl) 2007;48:276-83.

14. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127S-30S.

15. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-60.

16. Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099-107.

17. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Disponible en: http://www.goldcopd.org.

18. Incalzi RA, Fuso L, De Rosa, et al. Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99:1600-5.

19. Wilson DH, Tucker G, Frith P, et al. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust 2007; 186:408-11.

20. Pothirat C, Phetsuk N, Deesomchok A, Liwsrisakun C, et al. Clinical characteristics, management in real world practice and long-term survival among COPD patients of Northern Thailand COPD club members. J Med Assoc Thai 2007; 90:653-62.

21. 2001 Original: Executive Summary, Global Strategy for the Diagnosis, Management, and Prevention of COPD. Disponible en: http://www.goldcopd.com/Guidelineitem.asp

22. Yip JW, Chia BL, Tan WC. The ECG "lead I sign" in cardiac diseasean indicator of coexisting obstructive pulmonary disease. Singapore Med J 1999; 40:281-3.

23. Sodi-Pallares D, Medrano G, Bisteni A y col. Electrocardiografía clínica. Análisis deductivo. Editorial del Instituto Nacional de Cardiología, México, 1968;24:299-304.

24. Kilcoyne MM, Davis AL, Ferrer MI. A dynamic electrocardiographic concept useful in the diagnosis of cor pulmonale. Result of a survey of 200 patients with chronic obstructive pulmonary disease. Circulation 1970;42:903-24.

25. Zulli R, Donati P, Nicosia F, et al. Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease. Intern Emerg Med 2006;1:279-86.

26. Chazan R, Droszcz W. Electrocardiographic changes in patients with airway obstruction. Pol Arch Med Wewn 1992; 87:237-41.